Teoman Deger
Rotterdam, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Prognostic value of peri-operative circulating tumour DNA levels estimated by cell-free DNA methylation in patients with resectable colorectal liver metastases.
Journal: EBioMedicine
Published: October 21, 2025
CfDNA-based copy-number dynamics during anti-PD1 treatment in metastatic triple negative breast cancer.
Journal: Cell reports. Medicine
Published: August 06, 2024
Cell-free DNA aneuploidy score as a dynamic early response marker in prostate cancer.
Journal: Molecular oncology
Published: July 25, 2024
Hypermethylation of DNA Methylation Markers in Non-Cirrhotic Hepatocellular Carcinoma.
Journal: Cancers
Published: August 11, 2023
mFast-SeqS-based aneuploidy score in circulating cell-free DNA is a prognostic biomarker in prostate cancer.
Journal: Molecular oncology
Published: January 19, 2023
ESR1 Methylation Measured in Cell-Free DNA to Evaluate Endocrine Resistance in Metastatic Breast Cancer Patients.
Journal: International journal of molecular sciences
Published: April 02, 2022
Validity and utility of HER2/ERBB2 copy number variation assessed in liquid biopsies from breast cancer patients: A systematic review.
Journal: Cancer treatment reviews
Published: February 07, 2022
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
Journal: Molecular oncology
Published: October 04, 2021
High-throughput and affordable genome-wide methylation profiling of circulating cell-free DNA by methylated DNA sequencing (MeD-seq) of LpnPI digested fragments.
Journal: Clinical epigenetics
Published: April 27, 2021
A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients.
Journal: Cancers
Published: February 27, 2021
Last Updated: 09/26/2026